Sabadell Asabys et al. lead €14m series-E for MedLumics
Sabadell Asabys, VI Partners and CDTI Innvierte have led a €14m series-E round for Spanish healthcare device startup MedLumics.
Previous backers Andera Partners, Caixa Capital Risc and Innogest Capital also took part in the funding round.
Previous funding
In December 2011, Spanish venture capital firm Ysios Capital Partners led a €3.5m series-A for MedLumics alongside Caixa Capital Risc.
A venture capital syndicate led by Edmond de Rothschild Investment Partners (EdRip) invested €34.4m in the business in March 2017. Italian GP Innogest and Ireland-based Seroba Life Sciences participated, alongside an undisclosed strategic investor, while previous backers Ysios and Caixa Capital Risc also provided financing.
As part of the deal, EdRip partner Olivier Litzka and his peers Claudio Rumazza from Innogest and James Green from Seroba joined the company's board of directors.
Company
Founded in 2009 and headquartered in Madrid, MedLumics develops cardiac-related medical devices. The company's flagship product is the AblaView catheter, focused on the treatment of atrial fibrillation and other arrhythmias.
People
MedLumics – James Greene (CEO).
Asabys Partners – Josep Sanfeliu (managing partner).
More on Early-stage
Sidekick spinoffs: Insurtech scale-ups attract PE interest
Investment set to break EUR 1.1bn mark this year as sponsors seek for rising stars
World Fund leads EUR 128m raise for quantum computing group IQM
Series-A2 for Finnish startup focused on combating the climate crisis also backed by the EIB
Gorillas raises circa USD 1bn in Delivery Hero-led Series C
New funding comes just seven months after a Series B, with the company doubling in value
French mega-rounds shoot up in 2021
France has already seen as many rounds of EUR 100m and above than in 2019 and 2020 combined, Unquote Data shows
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater